Abstract Title:

Epigallocatechin Gallate Protects against TNFα- or HO- Induced Apoptosis by Modulating Iron Related Proteins in a Cell Culture Model.

Abstract Source:

Int J Vitam Nutr Res. 2019 Apr 8:1-8. Epub 2019 Apr 8. PMID: 30961459

Abstract Author(s):

Qi Xu, Anumantha G Kanthasamy, Manju B Reddy

Article Affiliation:

Qi Xu


Oxidative stress, iron dysregulation, and inflammation have been implicated in the pathogenesis of Parkinson's disease (PD). Considering the entwined relationship among these factors, epigallocatechin gallate (EGCG) may be a good candidate for PD treatment due to its protective effects against those factors. The objective of this study is to determine whether EGCG protects N27 dopaminergic neuronal cells from HO- and TNFα- induced neurotoxicity. Seven treatments were included: control, HOTNFα, FeSOHO + EGCGTNFα + EGCG, FeSO + EGCG. Cells were pretreated with 10 μM EGCG, followed by 50 μM HO, 30 ng/ml TNFα or 50 μM FeSO. Neuroprotective effects of EGCG were assessed by cell viability assay, caspase-3 activity, intracellular reactive oxygen species (ROS) generation, and iron related protein expressions. Caspase-3 activity was increased to 2.8 fold (P < 0.001) and 1.5 fold (P < 0.01) with HOand TNFα treatment; However, EGCG pretreatment significantly decreased the caspase activity by 50.2% (P < 0.001) and 30.1% (P < 0.05). Similarly, cell viability was reduced to 69.2% (P < 0.01) and 89% (P < 0.01) by HOand TNFα, which was partially blocked by EGCG pretreatment. Also, EGCG significantly (P < 0.001) protected against HO- induced ROS in a time dependent manner. In addition, both HOand TNFα significantly (P < 0.05) upregulated hepcidin expression and marginally reduced ferroportin (Fpn) expression unlike iron treatment alone. Collectively, our results show that EGCG protects against both TNFα- and HO- induced neuronal apoptosis. The observed neuroprotection may be through the inhibition of oxidative stress and inflammation which is possibly mediated mainly by hepcidin and partially by Fpn.

Study Type : In Vitro Study

Print Options

Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2020 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.